Vimarsana
Biggest News Aggregation in the World

Page 7 - Adxs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adxs Today - Breaking & Trending Today

StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS) - Vimarsana News

StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS)

Research analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded shares of Ayala Pharmaceuticals from a “neutral” rating to a “buy” rating in […]

StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS) - Vimarsana News

StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS)

StockNews.com began coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Free Report) in a research note issued to investors on Monday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded shares of Ayala Pharmaceuticals from a neutral rating to a buy rating in a research note on Tuesday, […]

StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS) - Vimarsana News

StockNews.com Initiates Coverage on Ayala Pharmaceuticals (OTCMKTS:ADXS)

StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded shares of Ayala Pharmaceuticals from a neutral rating to a buy rating in a report on Tuesday, May 30th. […]

Source: wkrb13.com
Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com - Vimarsana News

Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the stock. Ayala Pharmaceuticals Price Performance Ayala Pharmaceuticals Company Profile (Free Report) Ayala Pharmaceuticals, Inc, a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule […]

Ayala Pharmaceuticals (OTCMKTS:ADXS) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Ayala Pharmaceuticals (OTCMKTS:ADXS) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded shares of Ayala Pharmaceuticals from a neutral rating to a buy rating in a research report on Tuesday, May 30th. […]